 0001520138-17-000158.txt : 20170501 0001520138-17-000158.hdr.sgml : 20170501 20170428175359 accession number:		0001520138-17-000158 conformed submission type:	sc 13d public document count:		2 filed as of date:		20170501 date as of change:		20170428 subject company:	 	company data:	 		company conformed name:			grey cloak tech inc. 		central index key:			0001630176 		standard industrial classification:	services-computer processing & data preparation [7374] 		irs number:				472594704 		state of incorporation:			nv 		fiscal year end:			1231 	filing values: 		form type:		sc 13d 		sec act:		1934 act 		sec file number:	005-89602 		film number:		17797603 	business address:	 		street 1:		10300 w charleston 		street 2:		ste 13-378 		city:			las vegas 		state:			nv 		zip:			89135 		business phone:		(702) 201-6450 	mail address:	 		street 1:		10300 w charleston 		street 2:		ste 13-378 		city:			las vegas 		state:			nv 		zip:			89135 filed by:		 	company data:	 		company conformed name:			nejman joseph 		central index key:			0001705170 	filing values: 		form type:		sc 13d 	mail address:	 		street 1:		555 bryant st., suite 555 		city:			palo alto 		state:			ca 		zip:			94301 sc 13d 1 sc13d-greycloak.htm sc 13d united states securities and exchange commission washington, d.c. 20549 schedule 13d under the securities exchange act of 1934 (amendment no. )* grey cloak tech inc. (name of issuer) common stock, par value $0.001 per share (title of class of securities) 397845108 (cusip number) brian a. lebrecht c/o clyde snow &amp; sessions, p.c. 201 south main street, suite 1300 salt lake city, ut 84111 (name, address and telephone number of person authorized to receive notices and communications) march 31, 2017 (date of event which requires filing of this statement) if the filing person has previously filed a statement on schedule 13g to report the acquisition that is the subject of this schedule 13d, and is filing this schedule because of &sect;&sect;240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. * note : schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. see &sect;240.13d-7 for other parties to whom copies are to be sent. * the remainder of this cover page shall be filled out for a reporting person&#8217;s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. the information required on the remainder of this cover page shall not be deemed to be &#8220;filed&#8221; for the purpose of section 18 of the securities exchange act of 1934 (&#8220;act&#8221;) or otherwise subject to the liabilities of that section of the act but shall be subject to all other provisions of the act (however, see the notes). (page 1 of 6 pages) cusip no. 397845108 13d page 2 of 6 pages 1. names of reporting persons i.r.s. identification nos. of above persons (entities only ) joseph nejman 2. check the appropriate box if a member of a group &#9; (a) &#9744; (b) &#9746; 3. sec use only 4. source of funds oo 5. check box if disclosure of legal proceedings is required pursuant to item 2(d) or 2(e) &#9744; 6. citizenship or place of organization united states number of shares 7. sole voting power 43,647,216 beneficially owned by 8. shared voting power - each reporting 9. sole dispositive power 43,647,216 person with 10. shared dispositive power - 11. aggregate amount beneficially owned by each reporting person 43,647,216 12. check box if the aggregate amount in row (11) excludes certain shares &#9; 13. percent of class represented by amount in row (11) 40.17% 14. type of reporting person in cusip no. 397845108 13d page 3 of 6 pages item 1. security and issuer this statement on schedule 13d relates to the common stock, par value $0.001, of premier biomedical, inc., a nevada corporation (the &#8220;company&#8221;). the company&#8217;s current principal executive offices are located at 10300 w. charleston, las vegas, nv 89135. item 2. identity and background this statement is being filed by joseph nejman (sometimes referred to as the &#8220;reporting person&#8221;). mr. nejman&#8217;s address is: c/o the company, 10300 w. charleston, las vegas, nv 89135. mr. nejman is the president and a director of the company. during the last five years, mr. nejman has not been convicted in a criminal proceeding. during the last five years, mr. nejman has not been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding been subject to a judgment, decree or final order enjoining future violations or prohibiting or mandating activities subject to, federal or state securities law or finding any violation with respect to such law. mr. nejman is a citizen of the united states. item 3. source and amount of funds or other consideration on march 31, 2017, the company entered into a share exchange agreement by and among the company, sharerails, llc, a delaware limited liability company (&#8220;sharerails&#8221;), the reporting person, dmitry chourpo and joseph nejman, in his capacity as the selling members&#8217; representative, whereby the company issued and exchanged 91,619,170 shares of its common stock and 2,857,685 shares of its series a convertible preferred stock for all of the outstanding units of sharerails (the &#8220;exchange&#8221;). through the exchange, sharerails became a wholly-owned subsidiary of the company and the reporting person was appointed to the company&#8217;s board of directors and as an executive officer of the company. the reporting person exchanged all of his sharerails units for 7,500,000 shares of the company&#8217;s common stock and 6,024,536 shares of the company&#8217;s series a convertible preferred stock. each share of series a preferred stock is convertible at any time at the holder's option into six (6) fully paid and nonassessable shares of the company&#8217;s common stock and is subject to adjustment for stock splits, stock dividends, distributions, subdivisions, capital reorganization, reclassification and combinations. item 4. purpose of transaction the reporting person purchased the shares in the exchange based on the reporting person&#8217;s belief that the company&#8217;s securities received in the exchange, when purchased, represented an attractive investment opportunity. depending upon overall market conditions, other investment opportunities available to the reporting person, and the availability of shares at prices that would make the purchase or sale of shares desirable, the reporting person has and may continue to endeavor to increase or decrease his position in the company through, among other things, the purchase or sale of shares on the open market or in private transactions or otherwise, on such terms and at such times as the reporting person may deem advisable. except as set forth herein, the reporting person does not have any present plan or proposal which would relate to or result in any of the following: cusip no. 397845108 13d page 4 of 6 pages (a) the acquisition by any person of additional securities of the company, or the disposition of securities of the company; (b) an extraordinary corporate transaction, such as a merger, reorganization or liquidation, involving the company or any of its subsidiaries; (c) a sale or transfer of a material amount of assets of the company or any of its subsidiaries; (d) any change in the present board of directors or management of the company, including any plans or proposals to change the number or term of directors or to fill any existing vacancies on the board; (e) any material change in the present capitalization or dividend policy of the company; (f) any other material change in the company&#8217;s business or corporate structure, including but not limited to, if the company is a registered closed-end investment company, any plans or proposals to make any changes in its investment policy for which a vote is required by section 13 of the investment company act of 1940; (g) changes in the company&#8217;s charter, bylaws or instruments corresponding thereto or other actions which may impede the acquisition of control of the issuer by any person; (h) causing a class of securities of the issuer to be delisted from a national securities exchange or to cease to be authorized to be quoted in an inter-dealer quotation system of a registered national securities association; (i) a class of equity securities of the issuer becoming eligible for termination of registration pursuant to section 12(g)(4) of the act; or (j) any action similar to any of those enumerate above. the reporting person intends to review his investment in the company on a continuing basis. depending on various factors including, without limitation, the company&#8217;s financial position and investment strategy, the price levels of his securities, conditions in the securities markets and general economic and industry conditions, the reporting person may in the future take such actions with respect to his investment in the company as he deems appropriate, including: purchasing additional shares, exercising warrants to purchase shares, selling some or all of his shares, or changing his intention with respect to any and all matters referred to in this item 4. item 5. interest in securities of the issuer (a) the reporting person now beneficially owns 43,647,216 shares of the company&#8217;s common stock. based on 72,508,922 shares issued and outstanding as reported on the company&#8217;s form 10-k for the period ended december 31, 2016, the reporting person currently has beneficial ownership of 40.17% of the outstanding shares of the company&#8217;s common stock. the reporting person owns 7,500,000 shares of common stock and 6,024,536 shares of series a convertible preferred stock. each share of preferred stock is convertible into six (6) shares of common stock at any time at the holder&#8217;s option. cusip no. 397845108 13d page 5 of 6 pages (b) the reporting person owns the following rights with respect to the shares of the company&#8217;s common stock beneficially owned by him as of the date of this report: sole voting power: 43,647,216 shared voting power: - 0 - sole dispositive power: 43,647,216 shared dispositive power: - 0 &#8211; (c) the discussion above in item 3 regarding the exchange is incorporated herein by this reference. item 6. contracts, arrangements, understandings or relationships with respect to securities of the issuer on march 31, 2017, the reporting person entered into a shareholders agreement by and among the company, the reporting person, fred covely, william bossung and dmitry chourpo (each a &#8220;party&#8221; and collectively the &#8220;parties&#8221;). the parties agreed that no further issuances of series a convertible preferred stock would be made by the company without the unanimous consent of the parties. with certain exceptions for death, incapacity and estate planning transfers, the parties also agreed that no shares of the company&#8217;s common or preferred stock would be voluntarily sold, pledged, hypothecated, or otherwise transferred or permitted to be transferred in any manner or by any means whatsoever for a period of twelve (12) months from march 31, 2017. the shareholders agreement also gives the company the right to purchase the shares of a shareholder party upon that party&#8217;s death, incapacity, bankruptcy, withdrawal, divorce, dissolution, termination of the applicable commercial arrangement between the shareholder party and the company, or transfer in contravention of the shareholders agreement. if the company does not purchase such shares, the right to purchase then passes to the other shareholder parties, pro rata. this purchase right is terminated with respect to the reporting person when the reporting person individually and directly secures equity investments in the company of an aggregate of $2,000,000 during the reporting person&#8217;s employment with the company. item 7. material to be filed as exhibits the following documents are filed as exhibits to this schedule 13d: ex. 99.1- shareholders agreement dated march 31, 2017. cusip no. 397845108 13d page 6 of 6 pages signature after reasonable inquiry and to the best of my knowledge and belief, i certify that the information set forth in this statement is true, complete and correct. dated: april 28, 2017 /s/ joseph nejman name: joseph nejman ex-99.1 2 sc13d-greycloak_ex99z1.htm exhibit 99.1 shareholders agreement this shareholders agreement (this &ldquo; agreement &rdquo;) is entered into on march 31, 2017 (the &ldquo; effective date &rdquo;) by and between grey cloak tech inc., a nevada corporation (the &ldquo; company &rdquo;), fred covely, an individual (&ldquo; covely &rdquo;), william bossung, an individual (&ldquo; bossung &rdquo;), joseph nejman, an individual (&ldquo; nejman &rdquo;), and dmitry chourpo, an individual (&ldquo; chourpo &rdquo; and, together with covely, bossung, and nejman, each a &ldquo; shareholder &rdquo; and collectively the &ldquo; shareholders &rdquo;). each of the company and the shareholders may be referred to as a &ldquo; party &rdquo; and collectively as the &ldquo; parties .&rdquo; recitals whereas, the company, sharerails, llc, a delaware limited liability company (&ldquo; sharerails &rdquo;), nejman, chourpo, and the members of sharerails are all parties to that certain share exchange agreement dated march 31, 2017 (the &ldquo; exchange agreement &rdquo;), whereby the company acquired all of the issued and outstanding equity interests of sharerails; whereas, following the closing of the transactions contemplated by the exchange agreement, the shareholders will each own shares of company common stock (the &ldquo; common shares &rdquo;) and series a convertible preferred stock (the &ldquo; preferred shares &rdquo; and, together with the common shares, the &ldquo; shares &rdquo;) as set forth in exhibit a attached hereto and made a part hereof; whereas, the execution and delivery of this agreement is a condition precedent to, and an integral part of, the consideration flowing to the company for its consummation of the transactions contemplated by the exchange agreement including its issuance of the exchange shares as set forth therein. now, therefore, for good and adequate consideration, the receipt and sufficient of which is hereby acknowledged, the parties agree as follows: agreement 1. no issuance of preferred shares . the company will not, without the unanimous consent of all the shareholders, issue any shares of series a convertible preferred stock other than those set forth in exhibit a . 2. restrictions on transfer . no shares shall be voluntarily sold, pledged, hypothecated, or otherwise transferred or permitted to be transferred in any manner or by any means whatsoever, for a period of twelve (12) months following the effective date, without the unanimous consent of all the shareholders. notwithstanding the foregoing restrictions upon transfer and ownership, the following transfers are permitted: a. death of a shareholder . subject to section 3 , the personal representative of a deceased shareholder&rsquo;s estate or his or her contract beneficiary may exercise all of the decedent&rsquo;s rights and powers as a shareholder, and the decedent&rsquo;s shares will continue and pass to those entitled thereto upon the shareholder&rsquo;s death. it is specifically provided that a shareholder may prepare a written and acknowledged document in which he or she designates one or more beneficiaries of that shareholder&rsquo;s shares, and his or her written designation will be binding upon the company if delivered to the company within at least 60 days after the death of the shareholder. b. incapacity of a shareholder . subject to section 3 , the personal representative of an incapacitated shareholder, acting under a durable power of attorney or letters of guardianship may exercise all of a shareholder&rsquo;s rights and powers and will be entitled to receive distributions of cash or other property from the company. neither the company nor any shareholder will have a duty to inquire as to the application or use of funds delivered to a personal representative. c. estate planning transfers . subject to section 3 , a shareholder will also have the right to make estate-planning transfers of all or any part of his or her shares. the term &ldquo; estate planning transfer &rdquo; will mean any transfer made during the life of a shareholder without value, or for less than full consideration, by way of a marital partition agreement and/or a transfer of all or any part of the shares to a trust whose beneficiary or beneficiaries are the shareholder and/or the spouse of a shareholder, and/or the descendants of a shareholder, and/or one or more beneficiaries qualified to receive a charitable gift under section 170(c) of the internal revenue code of 1986, as amended, or any corresponding provision of any succeeding law (the &ldquo; code &rdquo;). this agreement will bind the transferee of any estate planning transfer to the exact terms and conditions of this agreement. 3. triggering events . on the happening of any of the following events (&ldquo; triggering events &rdquo;), the company and the other shareholders will have the option to purchase that portion of the shares of the applicable shareholder as set forth in exhibit b attached hereto and made a part hereof (&ldquo; selling shareholder &rdquo;) at the price and on the terms provided in section 4 of this agreement: a. the death, incapacity, bankruptcy, withdrawal, or divorce of a shareholder, or the winding up and dissolution of a shareholder, or the merger or other reorganization of a shareholder as a result of which the shareholder does not survive as an entity; b. the termination of the commercial arrangement between the shareholder and the company as set forth in exhibit b ; or c. the occurrence of any other event that is, or that would cause, a transfer in contravention of this agreement. &#9; each shareholder agrees to promptly give notice of a triggering event to the board of directors of the company. page 2 of 6 4. option to purchase . a. on the receipt of actual notice of any triggering event as determined in good faith by the board of directors of the company (the date of the receipt is hereinafter referred to as the &ldquo; option date &rdquo;), the company will promptly cause a notice of the occurrence of a triggering event to be sent to all shareholders, and the company will have the option, for a period ending 30 calendar days after the option date, to purchase the shares from the shareholder, at the price and on the terms set forth in exhibit b of this agreement, and the other shareholders, pro rata in accordance with their prior ownership of the shares, will then have the option, for a period of 30 days thereafter, to purchase the shares not purchased by the company, on the same terms and conditions as apply to the company. if all other shareholders do not elect to purchase all remaining shares, then the shareholders electing to purchase will have the right, pro rata in accordance with their prior ownership of the shares, to purchase the additional shares available for purchase. the transferee of the shares that are purchased will hold the shares subject to all of the provisions of this agreement. b. notwithstanding the foregoing, in the event nejman or bossung is individually and directly responsible for equity investments into the company of an aggregate of at least two million dollars ($2,000,000) (the &ldquo; threshold amount &rdquo;) during the employment term of the applicable employment agreement, the option to purchase pursuant to section 3 and section 4 shall be extinguished in its entirety but only with respect to the securities held by that shareholder, either nejman or bossung, who is directly and individually responsible for an aggregate of equity investments in excess of the threshold amount. nejman and bossung will each be deemed directly responsible for an equity investment if the investment was made as a result of a direct, personal contact with the investor by nejman or bossung, as the case may be, which does not include general solicitation or general marketing efforts. 5. miscellaneous . a. termination . this agreement shall terminate and all rights and obligations hereunder shall cease, upon the first to occur of (a) the agreement is terminated by written agreement of all the parties hereto, (b) the voluntary dissolution of the company, (c) none of the shareholders is the owner of any of the shares, or (d) twenty four (24) months after the effective date. b. amendments . this agreement may be altered, amended or modified in whole or in part at any time only by a writing signed by all the parties. c. severability . if any term or other provision of this agreement is invalid, illegal or incapable of being enforced by any rule or law, or public policy, page 3 of 6 all other conditions and provisions of this agreement shall nevertheless remain in full force and effect so long as the economic or legal substance of the transactions contemplated hereby is not affected in any manner materially adverse to any party. upon such determination that any term or other provision is invalid, illegal or incapable of being enforced, the parties hereto shall negotiate in good faith to modify this agreement so as to effect the original intent of the parties as closely as possible in an acceptable manner to the end that transactions contemplated hereby are fulfilled to the extent possible. d. entire agreement; no third-party beneficiaries . this agreement (i) constitutes the entire agreement and supersedes all prior agreements and understandings, both written and oral, among the parties with respect to the subject matter hereof, including but not limited to prior shareholders agreements, and (ii) is not intended to confer any rights or remedies hereunder upon, or be enforceable by, any person other than the parties hereto. e. governing law; venue . this agreement shall be governed by, and construed in accordance with, the laws of the state of nevada, regardless of the laws that might otherwise govern under applicable principles of conflicts of laws thereof. any dispute arising from the agreement shall be decided solely and exclusively by state or federal courts located in clark county, nevada. the parties agree to submit to the personal and exclusive jurisdiction of the state or federal courts located in clark county, nevada. f. assignment . neither this agreement nor any of the rights, interests or obligations under this agreement shall be assigned, in whole or in part, by operation of law or otherwise, by any party without the prior written consent of each of the other parties, and any purported assignment without such consent shall be void. subject to the preceding sentence, this agreement will be binding upon, inure to the benefit of, and be enforceable by, the parties and their respective successors and assigns. g. enforcement; venue . the parties agree that irreparable damage would occur in the event that any of the provisions of this agreement were not performed in accordance with their specific terms or were otherwise breached. it is accordingly agreed that the parties shall be entitled to an injunction or injunctions to prevent breaches of this agreement and to enforce specifically the terms and provisions of this agreement in any federal or state court located in the state of nevada, county of clark, this being in addition to any other remedy to which they are entitled at law or in equity. in addition, each of the parties hereto (i) consents to submit itself to the personal jurisdiction of any federal or state court located in the state of nevada, county of clark, in the event any dispute arises out of this agreement or any transaction contemplated hereby, (ii) agrees that it will not attempt to deny or defeat such personal jurisdiction by motion or other request for leave from any such court, (iii) agrees that it will not bring any action relating to this agreement or any transaction in any court other than a page 4 of 6 federal or state court sitting in the state of nevada, county of clark and (iv) waives any right to trial by jury with respect to any claim or proceeding related to or arising out of this agreement or any transaction contemplated hereby. h. remedies cumulative . all rights, powers and remedies provided under this agreement or otherwise available in respect hereof at law or in equity shall be cumulative and not alternative, and the exercise of any thereof by any party shall not preclude the simultaneous or later exercise of any other such right, power or remedy by such party. each of the parties confirms that damages at law may be an inadequate remedy for a breach or threatened breach of this agreement, and agrees that, in the event of a breach or threatened breach of any provision hereof, the respective rights and obligations hereunder shall be enforceable by specific performance, injunction or other equitable remedy, but nothing herein contained is intended to, nor shall it, limit or affect any rights or rights at law or by statute or otherwise of any party aggrieved as against the other for breach or threatened breach of any provision hereof, it being the intention by this paragraph to make clear the agreement of the parties that the respective rights and obligations of the parties hereunder shall be enforceable in equity as well as at law or otherwise. i. attorney fees . in the event any party hereto shall bring any action or proceeding to enforce any provision of this agreement against any other party (or any transferee or rights pursuant hereto), the prevailing party, whether at trial or on appeal, shall be entitled to recover reasonable attorney fees, costs and disbursements in addition to any other relief to which such party is entitled. [remainder of page intentionally left blank; signature page to follow] page 5 of 6 in witness whereof, the parties have executed this shareholders agreement as of the date first set forth above. &ldquo; company &rdquo; &ldquo; shareholders &rdquo; grey cloak tech inc., a nevada corporation /s/ fred covely&#9; fred covely /s/ fred covely&#9; by:&#9;fred covely its:&#9;president /s/ william bossung&#9; william bossung /s/ joseph nejman&#9; joseph nejman /s/ dmitry chourpo&#9; dmitry chourpo page 6 of 6 exhibit a shares name common shares preferred shares fred covely 7,500,000 6,024,536 william bossung 7,500,000 6,024,536 dmitry chourpo 7,500,000 6,024,536 joseph nejman 7,500,000 6,024,536 totals 30,000,000 24,098,144 exhibit b triggering events; option to purchase shareholder commercial arrangement (section 3(b)) option to purchase (section 3) purchase price and terms (section 4) fred covely termination of that certain business development agreement dated march 31, 2017. one half (1/2) of the shareholder&rsquo;s shares shall vest immediately and not be subject to purchase. one-fourth (1/4) of the shareholder&rsquo;s shares shall be subject to purchase during the first twelve (12) months after the effective date. one-fourth (1/4) of the shareholder&rsquo;s shares shall be subject to purchase during the first twenty four (24) months after the effective date. the purchase price shall be fifty thousand dollars ($50,000) for each one-fourth (1/4) of the shareholder&rsquo;s shares. if the purchase price is fifty thousand dollars ($50,000) or less, the purchase price shall be paid in two (2) equal installments, one at the time of purchase and one twelve (12) months later. if the purchase price is over fifty thousand dollars ($50,000), the purchase price shall be paid in four (4) equal installments, one at the time of purchase and one every twelve (12) months thereafter. william bossung termination of that certain employment agreement dated march 31, 2017. joseph nejman termination of that certain employment agreement dated march 31, 2017. dmitry chourpo termination of that certain business development agreement dated april 1, 2017. 